Pfizer to license COVID-19 antiviral

被引：0
|
作者：
McCoy, Michael
机构：
来源：
CHEMICAL & ENGINEERING NEWS | 2021年 / 99卷 / 42期
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [1] Pfizer tests COVID-19 antiviral
    Halford, Bethany
    CHEMICAL & ENGINEERING NEWS, 2020, 98 (37) : 9 - 9
  • [2] Covid-19: Campaigners accuse Pfizer of blocking access to antiviral for trials in poorer countries
    Thornton, Jacqui
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 376 : o721
  • [3] Pfizer: The miracle vaccine for COVID-19?
    Badiani, A. A.
    Patel, J. A.
    Ziolkowski, K.
    Nielsen, F. B. H.
    PUBLIC HEALTH IN PRACTICE, 2020, 1
  • [4] Pfizer-BioNTech COVID-19 Vaccine
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1642): : 16 - 16
  • [5] Antiviral treatment of COVID-19
    Simsek Yavuz, Serap
    Unal, Serhat
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2020, 50 : 611 - 619
  • [6] Favipiravir, an antiviral for COVID-19?
    Coomes, Eric A.
    Haghbayan, Hourmazd
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (07) : 2013 - 2014
  • [7] Antiviral Therapy of COVID-19
    Gudima, Georgii
    Kofiadi, Ilya
    Shilovskiy, Igor
    Kudlay, Dmitry
    Khaitov, Musa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [8] An antiviral drug for covid-19?
    Benestad, Haakon B.
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2021, 141 (12) : 1176 - 1176
  • [9] The path to Paxlovid How Pfizer scientists transformed an old drug lead into an oral COVID-19 antiviral
    Halford, Bethany
    CHEMICAL & ENGINEERING NEWS, 2022, 100 (03) : 16 - 18
  • [10] Reactogenicity and Immunogenicity of the Pfizer and AstraZeneca COVID-19 Vaccines
    Mahallawi, Waleed H.
    Mumena, Walaa A.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
12345